Copanlisib in the Treatment of Relapsed Follicular Lymphoma: Utility and Experience from the Clinic

The phosphatidylinositol-3-kinase (PI3K) pathway is ubiquitous to multiple cellular processes and is intricately implicated in lymphomagenesis. The development of PI3K inhibitors has broadened treatment options for relapsed and/or refractory follicular lymphoma (FL) and currently three PI3K inhibito...

Descripción completa

Detalles Bibliográficos
Autores principales: Chauhan, Ayushi F, Cheson, Bruce D
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7846853/
https://www.ncbi.nlm.nih.gov/pubmed/33531838
http://dx.doi.org/10.2147/CMAR.S201024

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7846853/
https://www.ncbi.nlm.nih.gov/pubmed/33531838
http://dx.doi.org/10.2147/CMAR.S201024

Ejemplares similares